Shahmiri M, Enciso M, Adda CG, Smith BJ, Perugini MA, Mechler A
It functions as a dual GLP-1 and GIP receptor agonist , offering: Enhanced insulin secretion Delayed gastric emptying Appetite suppression Improved glycemic control Tirzepatide demonstrated impressive clinical outcomes in the SURMOUNT and SURPASS trials, with average weight loss of 15-22.5% and substantial A1C reductions
Regular follow-ups with the healthcare provider are essential to monitor progress and adjust dosages as needed
Background Observations from phase-3 clinical trials like SUSTAIN and PIONEER indicated anti-obesity potential of semaglutide, which was established in STEP trials
HIPAA-secure | Only pay if prescribed *Displayed price reflects a 3-month plan
Vitamin K helps maintain bone mineral density and may help prevent bone fractures and osteoporosis, it may also help to prevent calcium buildup in arteries